Similar to TRPV6 and TRPV2 (poor prognosis with high expression in numerous cancers), high expression of the PM Ca2+ ATPase 2 (PMCA2) conferred resistance to apoptosis and was associated with a poor prognosis [32]. The gene discussed is TRPV2; the disease is cancer.